DUBLIN, April 8, 2019 /PRNewswire/ — The “Latin America Cell Analysis Market: Focus on Products Type, End Users, 5 Countries Data, Industry Insights, and Competitive Landscape – Analysis and Forecast, 2019-2025” report has been added to ResearchAndMarkets.com’s offering.
The Latin America cell analysis market is anticipated to reach $1,566.7 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025.
Technological innovations in the healthcare industry have opened up new avenues for better treatment, and prevention approaches, for infectious and non-infectious diseases globally. The changes and innovations in the healthcare industry have changed the experiences of patients, outcomes of chronic diseases, and improved practices of healthcare professionals. A significant degree of research on molecular technologies and cellular biomarkers presence in body fluids have opened various pathways for the development of cellular heterogeneity analysis and molecular level analysis of pathways and processes.
Some of the factors such as growing inclination towards single-cell technology, increasing prevalence of chronic diseases, technological advancements of cell analysis instruments, increasing support from governments of countries in Latin America for cell-based research activities, and increasing number of contract research organizations providing outsourcing services are bolstering the growth of the Latin America cell analysis market.
In terms of product type, the Latin America cell analysis market is dominated by consumables. The impressive growth in the demand for consumables, which includes assays, reagents and labeling kits, among others, is attributed to the elevated requirement for specialty chemicals and assays intended for research activities and therapeutic purposes.
Further, the installation of new cell analysis units and replacement of old ones is bolstering the growth of the Latin America cell analysis market. Cell-based flow cytometry is a major domain that is gaining popularity owing to its ease of use, high accuracy, and sensitivity. Increasing awareness pertaining to the use of cell-based assays is further supporting the use of cell-based flow cytometer.
In terms of end user, the Latin America cell analysis market is dominated by pharmaceutical and biotechnology companies. The growth can be accounted to the increased awareness and adoption of cell analysis tests for an early detection and treatment of infectious diseases.
The shift from chemical-based small molecules to the biology-based larger molecules such as protein and antibodies is supporting the growth of the pharmaceutical and biotechnology companies’ segment. Latin America majorly focuses on research for the development of relevant drugs and providing vital real-time information on tumor profiles and chronic diseases, further facilitating the prognosis and treatment approach for healthcare professionals.
In terms of country, Brazil is the leading contributor to the Latin America cell analysis market. The growing geriatric population and rising prevalence of different types of cancer have significantly elevated the requirement of novel cell analysis technologies which enable real-time monitoring, diagnosis, and prognosis in the country.
Key Topics Covered:
1 Market Overview
1.1 Role of Biomarkers in Cell Analysis
1.2 Recent Advancements in Cell Analysis
1.3 Trends for Latin America Cell Analysis Market
1.4 Cell Analysis Market: Future Potential
1.5 Latin America Cell Analysis Market Scenario
2 Market Dynamics
2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Growing inclination towards single cell technology
2.2.2 Increasing focus on cell-based research across countries of Latin America
2.2.3 Increasing number of contract research organizations (CROs)
2.2.4 Rising awareness about regenerative medicine among individuals
2.2.5 Advancement in cell imaging and analysis technologies eased drug discovery process
2.3 Market Restraints
2.3.1 Stringent regulatory framework on cell analysis systems and assays
2.3.2 High costs associated with the cell analysis instruments
2.4 Market Opportunities
2.4.1 Offering of high-content screening services by contract research organizations (CROs)
2.4.2 Automation of cancer cell analysis techniques
3 Competitive Insights
3.1 Market Share Analysis
3.2 Industry Attractiveness
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyer
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitute Products
3.2.5 Intensity of Competitive Rivalry
4 Latin America Cell Analysis Market (by Product Type)
4.1.1 Cell Imaging Systems and Microscopes
4.1.2 Flow Cytometer
4.1.3 Quantitative PCR (qPCR) Instruments
4.1.4 Cell Counters
4.1.5 Cell Screening and High-Content Screening Systems (HCS)
4.1.6 Other Instruments
4.2.1 Assay Kits
4.2.3 Other Consumables
5 Latin America Cell Analysis Market (by End User)
5.2 Pharmaceutical and Biotechnology Companies
5.3 Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
5.4 Academic and Research Institutes
5.5 Other End User
6 Latin America Cell Analysis Market (by Country)
6.6 Rest-of-Latin America (RoLA)
7 Company Profiles
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F.Hoffmann-La Roche AG
- GE Corporation
- Merck & Co., Inc.
- Olympus Corporation
- Perkin Elmer, Inc.
- QIAGEN N.V.
- Sony Biotechnology Inc.
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/8k8lxh/latin_america?w=5
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets